Yuchun Lee - May 1, 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
Director
Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
May 1, 2022
Transactions value $
$0
Form type
4
Date filed
5/3/2022, 04:53 PM
Previous filing
Apr 20, 2022
Next filing
Jan 19, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRTX Stock Option (Right to Buy) Award $0 +4.46K $0.00 4.46K May 1, 2022 Common Stock 4.46K $276.17 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.